Infigratinib (BGJ398)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 01:44, 2 June 2021 by Jwarner (talk | contribs) (Jwarner moved page Infigratinib (BGJ398) to Infigratinib (Truseltiq): FDA approval with new brand name)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Redirect page
Jump to navigation Jump to search

Redirect to:

Retrieved from "https://hemonc.org/w/index.php?title=Infigratinib_(BGJ398)&oldid=50189"